Ripretinib in the treatment of patients with advanced gastrointestinal stromal tumors (GIST)

Babula, E; Sikora, A; Sobczuk, P; Rutkowski, P

Sobczuk, P (通讯作者),Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Ul Roentgena 5, PL-02781 Warsaw, Poland.

ONCOLOGY IN CLINICAL PRACTICE, 2023; ():

Abstract

Gastrointestinal stromal tumors (GISTs) are relatively rare in the population (0.4 to 2 cases per 100 000 per year) and account for approximately 1-2%......

Full Text Link